Logo image of AMK

AssetMark Financial Holdings Inc (AMK) Stock Fundamental Analysis

USA - NYSE:AMK - US04546L1061 - Common Stock

35.24 USD
-0.02 (-0.06%)
Last: 9/4/2024, 8:18:01 PM
35.25 USD
+0.01 (+0.03%)
After Hours: 9/4/2024, 8:18:01 PM
Fundamental Rating

6

Overall AMK gets a fundamental rating of 6 out of 10. We evaluated AMK against 237 industry peers in the Capital Markets industry. AMK has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMK has a correct valuation and a medium growth rate. With these ratings, AMK could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year AMK was profitable.
AMK had a positive operating cash flow in the past year.
In multiple years AMK reported negative net income over the last 5 years.
AMK had a positive operating cash flow in each of the past 5 years.
AMK Yearly Net Income VS EBIT VS OCF VS FCFAMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 8.86%, AMK belongs to the top of the industry, outperforming 85.65% of the companies in the same industry.
With a Return On Equity value of 10.65%, AMK perfoms like the industry average, outperforming 58.80% of the companies in the same industry.
AMK has a better Return On Invested Capital (10.75%) than 84.72% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMK is in line with the industry average of 7.58%.
The last Return On Invested Capital (10.75%) for AMK is above the 3 year average (6.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.86%
ROE 10.65%
ROIC 10.75%
ROA(3y)5.44%
ROA(5y)3.13%
ROE(3y)7.14%
ROE(5y)4.1%
ROIC(3y)6.53%
ROIC(5y)4.35%
AMK Yearly ROA, ROE, ROICAMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

AMK has a Profit Margin of 19.43%. This is comparable to the rest of the industry: AMK outperforms 56.02% of its industry peers.
AMK's Profit Margin has improved in the last couple of years.
AMK has a Operating Margin of 30.00%. This is comparable to the rest of the industry: AMK outperforms 52.31% of its industry peers.
In the last couple of years the Operating Margin of AMK has grown nicely.
AMK has a better Gross Margin (77.45%) than 80.09% of its industry peers.
AMK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 30%
PM (TTM) 19.43%
GM 77.45%
OM growth 3Y173.66%
OM growth 5Y12.1%
PM growth 3YN/A
PM growth 5Y11.06%
GM growth 3Y3.85%
GM growth 5Y2.66%
AMK Yearly Profit, Operating, Gross MarginsAMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, AMK has more shares outstanding
The number of shares outstanding for AMK has been increased compared to 5 years ago.
AMK has a better debt/assets ratio than last year.
AMK Yearly Shares OutstandingAMK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
AMK Yearly Total Debt VS Total AssetsAMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

AMK has an Altman-Z score of 7.20. This indicates that AMK is financially healthy and has little risk of bankruptcy at the moment.
AMK has a better Altman-Z score (7.20) than 91.20% of its industry peers.
There is no outstanding debt for AMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.2
ROIC/WACCN/A
WACCN/A
AMK Yearly LT Debt VS Equity VS FCFAMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

AMK has a Current Ratio of 3.27. This indicates that AMK is financially healthy and has no problem in meeting its short term obligations.
AMK has a Current ratio of 3.27. This is amongst the best in the industry. AMK outperforms 81.94% of its industry peers.
AMK has a Quick Ratio of 3.27. This indicates that AMK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.27, AMK belongs to the best of the industry, outperforming 81.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
AMK Yearly Current Assets VS Current LiabilitesAMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

AMK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.89%, which is quite impressive.
AMK shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.75% yearly.
Looking at the last year, AMK shows a quite strong growth in Revenue. The Revenue has grown by 8.67% in the last year.
AMK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.27% yearly.
EPS 1Y (TTM)22.89%
EPS 3Y31.37%
EPS 5Y23.75%
EPS Q2Q%20%
Revenue 1Y (TTM)8.67%
Revenue growth 3Y17.92%
Revenue growth 5Y14.27%
Sales Q2Q%4.11%

3.2 Future

Based on estimates for the next years, AMK will show a small growth in Earnings Per Share. The EPS will grow by 7.93% on average per year.
Based on estimates for the next years, AMK will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y16.44%
EPS Next 2Y10.33%
EPS Next 3Y6.26%
EPS Next 5Y7.93%
Revenue Next Year-6.11%
Revenue Next 2Y-1.18%
Revenue Next 3Y0.72%
Revenue Next 5Y4.07%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMK Yearly Revenue VS EstimatesAMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
AMK Yearly EPS VS EstimatesAMK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.27 indicates a correct valuation of AMK.
AMK's Price/Earnings is on the same level as the industry average.
AMK is valuated rather cheaply when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.64, which indicates a correct valuation of AMK.
The rest of the industry has a similar Price/Forward Earnings ratio as AMK.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, AMK is valued a bit cheaper.
Industry RankSector Rank
PE 14.27
Fwd PE 12.64
AMK Price Earnings VS Forward Price EarningsAMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMK is valued cheaply inside the industry as 87.04% of the companies are valued more expensively.
AMK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 21.82
EV/EBITDA 9.25
AMK Per share dataAMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AMK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.87
PEG (5Y)0.6
EPS Next 2Y10.33%
EPS Next 3Y6.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AssetMark Financial Holdings Inc

NYSE:AMK (9/4/2024, 8:18:01 PM)

After market: 35.25 +0.01 (+0.03%)

35.24

-0.02 (-0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-18 2024-07-18/amc
Earnings (Next)11-04 2024-11-04/amc
Inst Owners0.72%
Inst Owner Change0%
Ins Owners3.83%
Ins Owner Change0%
Market Cap2.64B
Analysts72.5
Price Target37.13 (5.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.44%
Min EPS beat(2)-1.49%
Max EPS beat(2)-1.4%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-1.49%
Max EPS beat(4)5.84%
EPS beat(8)4
Avg EPS beat(8)1.65%
EPS beat(12)7
Avg EPS beat(12)2.09%
EPS beat(16)10
Avg EPS beat(16)2.94%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)-1.79%
Revenue beat(4)1
Avg Revenue beat(4)3.36%
Min Revenue beat(4)-16.64%
Max Revenue beat(4)34.37%
Revenue beat(8)4
Avg Revenue beat(8)2.49%
Revenue beat(12)8
Avg Revenue beat(12)11.44%
Revenue beat(16)12
Avg Revenue beat(16)19.73%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.49%
Valuation
Industry RankSector Rank
PE 14.27
Fwd PE 12.64
P/S 3.58
P/FCF 21.82
P/OCF 15.64
P/B 1.96
P/tB 43.75
EV/EBITDA 9.25
EPS(TTM)2.47
EY7.01%
EPS(NY)2.79
Fwd EY7.91%
FCF(TTM)1.62
FCFY4.58%
OCF(TTM)2.25
OCFY6.39%
SpS9.85
BVpS17.98
TBVpS0.81
PEG (NY)0.87
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 8.86%
ROE 10.65%
ROCE 14.43%
ROIC 10.75%
ROICexc 12.47%
ROICexgc 447.49%
OM 30%
PM (TTM) 19.43%
GM 77.45%
FCFM 16.39%
ROA(3y)5.44%
ROA(5y)3.13%
ROE(3y)7.14%
ROE(5y)4.1%
ROIC(3y)6.53%
ROIC(5y)4.35%
ROICexc(3y)7.43%
ROICexc(5y)4.92%
ROICexgc(3y)420.6%
ROICexgc(5y)N/A
ROCE(3y)8.77%
ROCE(5y)5.83%
ROICexcg growth 3Y241.08%
ROICexcg growth 5YN/A
ROICexc growth 3Y204.19%
ROICexc growth 5Y21.2%
OM growth 3Y173.66%
OM growth 5Y12.1%
PM growth 3YN/A
PM growth 5Y11.06%
GM growth 3Y3.85%
GM growth 5Y2.66%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 123.53%
Cap/Sales 6.48%
Interest Coverage 26.26
Cash Conversion 64.87%
Profit Quality 84.33%
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z 7.2
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)163.76%
Cap/Depr(5y)129.64%
Cap/Sales(3y)8.88%
Cap/Sales(5y)7.75%
Profit Quality(3y)175.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.89%
EPS 3Y31.37%
EPS 5Y23.75%
EPS Q2Q%20%
EPS Next Y16.44%
EPS Next 2Y10.33%
EPS Next 3Y6.26%
EPS Next 5Y7.93%
Revenue 1Y (TTM)8.67%
Revenue growth 3Y17.92%
Revenue growth 5Y14.27%
Sales Q2Q%4.11%
Revenue Next Year-6.11%
Revenue Next 2Y-1.18%
Revenue Next 3Y0.72%
Revenue Next 5Y4.07%
EBIT growth 1Y46.53%
EBIT growth 3Y222.7%
EBIT growth 5Y28.1%
EBIT Next Year24.57%
EBIT Next 3Y10.53%
EBIT Next 5Y10.69%
FCF growth 1Y26.81%
FCF growth 3Y38.63%
FCF growth 5Y23.51%
OCF growth 1Y28.71%
OCF growth 3Y31.45%
OCF growth 5Y23.14%